Clinical Trials Browser

Phase 2 × Lymphedema × 90 days × Clear all

NCT06868238 2026-02-18

Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)

Phase 2 Withdrawn

Carcinoma, Intraductal, Noninfiltrating, Lymphedema

NCT06912763 2026-01-26

Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)

Phase 2 Recruiting

Fibrosis, Head and Neck Neoplasms, Lymphedema